Autism Clinical Trial
Official title:
The Effects of a Clean Room Sleeping Environment on Elemental and Chemical Concentrations in Children and Adolescents With Autism Spectrum Disorders
A child and their parent were asked to participate in a research project that sought to
study whether sleeping in a very clean environment for 14 days improved the elimination of
chemicals and metals from the child's body. The child had an approximately two hour
evaluation to confirm his or her diagnosis of Autism or Pervasive Developmental Disorder.
Not Otherwise Specified. When one of these diagnoses was confirmed the child was scheduled
to spend 14 nights sleeping in a very clean environment in a specially created room at The
Children's Institute.
Several hours prior to the first night the child slept in the clean room the child's mother,
father, or guardian filled out behavioral rating scales about the child with the assistance
of the study's research coordinator. The child also had approximately two tablespoons of
blood drawn from an arm and a few inch sample of hair was taken from the back of the child's
head. The child and a parent or guardian arrived at The Children's Institute about one half
hour prior to the child's normal time of settling for bed for 14 consecutive nights. The
child and a parent or guardian slept in the clean room, wearing the provided very clean
clothes and sleeping on special mattresses and sheets each night for 14 consecutive nights.
The child and parent were observed by a nurse through a window during the time in the clean
room. The child and parent participated in regular daytime activities during these 14 days
of the study. On the morning after the last night the child and a parent or guardian slept
in the clean room a parent or guardian filled out behavioral rating scales with the help of
the research coordinator. Approximately two tablespoons of blood were drawn from an arm and
a few inch sample of hair was obtained from the back of the child's head, at The Children's
Institute or at home.
Autism spectrum disorders are characterized behaviorally by expressive language and social
deficits, the performance of stereotypic and repetitive behavior patterns, and abnormal
cognitive functioning. Children with autism spectrum disorders often do not have known
anomalies seen on genetic testing. An emerging paradigm suggests that the majority of
children with autism are displaying a pattern of genetic / environmental interaction that
make them susceptible to difficulties with detoxification of the heavy metal and chemical
environment. Children with autism demonstrate increased difficulty with the performance of
methylation and sulfation required for the elimination of fat soluble chemicals from human
tissues. These children also commonly display dysfunction of their metalloprotein systems
necessary for the elimination of heavy metals such as mercury and arsenic from their bodies.
This study sought to provide 10 children with autism an opportunity to sleep in a clean room
environment, a hospital room that was modified to remove nearly all traces of particulate
matter, chemicals, and heavy metals, for a 2 week period while going about their normal
activities during the day. In the clean room, the children slept on bedding and wore clothes
that did not release any toxins. This room created a concentration gradient for chemical and
heavy metal toxins that may have allowed these toxins to leave the children's bodies during
their stays.
The children's parents filled out seven rating scales, including the Aberrant Behavior
Checklist, immediately before and after the 2 week sleeping periods. The children had blood
samples taken before and after the 2 week sleeping experiences that measured biomarkers of
metalloprotein (heavy metal elimination) and immune functioning, such as the plasma
zinc/serum copper ratio and T and B cell subsets. Red blood cell and hair concentrations of
toxic heavy metals such as mercury, arsenic, and chromium 6, and red blood cell
concentrations of chemicals implicated in contributing to human pathology, including
polychlorinated biphenyls (PCBs), polybrominated diethyl ethers (PBDEs), and phthalates were
determined before and after the sleeping experiences. These pre and post stay variables were
statistically compared, and it was hypothesized that the children's red blood cell
concentrations of toxins would be significantly reduced while their hair concentrations of
toxins would be significantly increased after their sleeping experiences in the clean room,
supporting the concept that the clean room promoted the release of heavy metals and
chemicals from their bodies. This one year study was a proof of concept cohort study.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05302167 -
Molehill Mountain Feasibility Study.
|
N/A | |
Completed |
NCT04167839 -
Effects of Sensory Diets on Children's Sensory Processing Skills, Psychosocial Skills, and Classroom Engagement
|
N/A | |
Terminated |
NCT04049981 -
Investigation of Mechanisms of Action in Superpower Glass
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT06080087 -
Implementation Toolkit to Enhance EBP Among Marginalized Families
|
N/A | |
Recruiting |
NCT04107064 -
Achieving Steady Work Among Adults With Autism Through Specialized Employment Program
|
N/A | |
Completed |
NCT03206996 -
Exposure Therapy for Auditory Sensitivity in Autism
|
N/A | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Completed |
NCT05588570 -
Coaching Children With Anxiety and Autism Through Telehealth
|
N/A | |
Enrolling by invitation |
NCT06058104 -
Evaluating Efficacy of a Digital Game Therapeutic for Children With Autism
|
N/A | |
Withdrawn |
NCT02414451 -
Trial of Propranolol in Adults and Adolescents With ASD and Predictors of Response
|
N/A | |
Completed |
NCT02911194 -
a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT03002363 -
The Effects of Video Modeling of Audiological Testing on Pediatric Patient Compliance
|
Phase 1 | |
Completed |
NCT02847182 -
Cord Blood Infusion for Children With Autism Spectrum Disorder
|
Phase 2 | |
Completed |
NCT02508922 -
Trial of Vitamin D3 Supplementation in Paediatric Autism
|
N/A | |
Completed |
NCT02536365 -
Sensory Integration Therapy in Autism: Mechanisms and Effectiveness
|
N/A | |
Completed |
NCT02720900 -
Prebiotic Intervention for Autism Spectrum Disorders
|
N/A | |
Completed |
NCT02708290 -
Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD
|
||
Recruiting |
NCT02255565 -
Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study
|
Phase 4 | |
Recruiting |
NCT01836562 -
A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism
|
Phase 1/Phase 2 | |
Completed |
NCT02154828 -
Clinical Evaluation of Integrative Practices Units Infant and Child Care for Unit Children With Typical or Atypical Autism (AUTISM)
|